98%
921
2 minutes
20
Background: Lower limb lymphedema can cause significant physical and psychological distress. Complete decongestive therapy is recognized as the gold standard for non-surgical management of this condition. However, the lived experiences of patients undergoing complete decongestive therapy have been largely overlooked in existing research.
Objectives: To explore the experiences of individuals with lower limb lymphedema undergoing complete decongestive therapy.
Methods: A total of 18 eligible participants with lower limb lymphedema, aged 39-72 years, were recruited through purposive sampling from a hospital in China. One-on-one in-depth interviews were conducted to collect qualitative data. Nvivo12.0 was used for data encoding and management, and Colaizzi's descriptive analysis framework was employed for data interpretation.
Results: Four major themes and thirteen subthemes were generated from the data analysis: (a) Physical discomfort, (b) Increased confidence, (c) Emotional distress, and (d) Need for support.
Conclusion: People undergoing complete decongestive therapy for lower limb lymphedema experience complex physical, emotional, and psychological challenges. Interventions to enhance the complete decongestive therapy experience should focus on five key areas: health education, psychological support, advancements in medical devices, the establishment of consultation platforms, and addressing self-care difficulties among individuals living alone.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpsychores.2025.112351 | DOI Listing |
Cureus
July 2025
Department of Otolaryngology, Head and Neck Surgery, Qassim University, Buraidah, SAU.
Background: Nasal congestion, a common symptom of various upper respiratory conditions, is often treated with nasal decongestants, which are effective vasoconstrictors used to relieve blockage in conditions like allergic rhinitis, rhinosinusitis, and nasal polyps. However, frequent use of these decongestants can lead to both local and systemic side effects.
Methods: This cross-sectional study used an online, self-administered questionnaire to collect data from our population as regard on the inclusion and exclusion criteria.
J Korean Med Sci
August 2025
Department of Pharmacology, College of Medicine, Yeungnam University, Daegu, Korea.
Background: Vascular smooth muscle cells (VSMCs) play an important role in regulating vessel diameter and blood pressure. Dysregulation of VSMC contraction contributes to the development of coronary and post-subarachnoid hemorrhagic (SAH) vasospasms. We investigated the molecular mechanisms by which valproic acid (VPA) inhibits Ras homolog family member A (RhoA)-mediated VSMC contraction in rat VSMCs and isolated aortas.
View Article and Find Full Text PDFJ Am Soc Echocardiogr
August 2025
Cardiology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS - Brazil; Postgraduate Program in Cardiology: Cardiovascular Science, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS - Brazil.
Background: Quantifying systemic venous congestion in acute decompensated heart failure is challenging. The Venous Excess Ultrasound (VExUS) score has emerged as a noninvasive tool for assessing venous congestion. Although higher VExUS values are linked to cardiorenal syndrome, its prognostic role in ADHF remains unclear.
View Article and Find Full Text PDFJ Psychosom Res
August 2025
China-Japan Union Hospital of Jilin University, Changchun, China. Electronic address:
Background: Lower limb lymphedema can cause significant physical and psychological distress. Complete decongestive therapy is recognized as the gold standard for non-surgical management of this condition. However, the lived experiences of patients undergoing complete decongestive therapy have been largely overlooked in existing research.
View Article and Find Full Text PDFLymphat Res Biol
August 2025
Brylan's Feat Foundation, Scottsdale, Arizona 85251, USA.
To determine whether a 4-day, twice-daily complete decongestive therapy (CDT) intervention effectively reduces limb volume in pediatric patients with primary and secondary lymphedema. A retrospective cohort study was conducted using rehabilitation records of children aged 5-17 years from Camp Watchme, a North American summer camp providing lymphedema interventions. Over 4 years, 38 unique campers contributed 66 records for analysis.
View Article and Find Full Text PDF